MCLAUGHLIN BODY COMPANY has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan MCLAUGHLIN BODY COMPANY PRESCRIPTION DRUG PLAN FOR RETIRED EMPLOYEES
| Measure | Date | Value |
|---|
| 2025 : MCLAUGHLIN BODY COMPANY PRESCRIPTION DRUG PLAN FOR RETIRED EMPLOYEES 2025 401k financial data |
|---|
| Total expenses incurred by plan in this plan year | 2025-10-08 | 36589 |
| Net assets as of the end of the plan year | 2025-10-08 | 9893256 |
| Total assets as of the beginning of the plan year | 2025-10-08 | 9022511 |
| Value of plan covered by a fidelity bond | 2025-10-08 | 3000000 |
| Other income to plan in this plan year | 2025-10-08 | 907334 |
| Plan net income in this plan year | 2025-10-08 | 870745 |
| Net assets as of the end of the plan year | 2025-10-08 | 9893256 |
| Net assets as of the beginning of the plan year | 2025-10-08 | 9022511 |
| Expensese paid to adminstrative service provicers from plan in this plan year | 2025-10-08 | 36589 |
| 2024 : MCLAUGHLIN BODY COMPANY PRESCRIPTION DRUG PLAN FOR RETIRED EMPLOYEES 2024 401k financial data |
|---|
| Total expenses incurred by plan in this plan year | 2024-10-10 | 32830 |
| Net assets as of the end of the plan year | 2024-10-10 | 9022511 |
| Total assets as of the beginning of the plan year | 2024-10-10 | 7956548 |
| Value of plan covered by a fidelity bond | 2024-10-10 | 3000000 |
| Other income to plan in this plan year | 2024-10-10 | 1098793 |
| Plan net income in this plan year | 2024-10-10 | 1065963 |
| Net assets as of the end of the plan year | 2024-10-10 | 9022511 |
| Net assets as of the beginning of the plan year | 2024-10-10 | 7956548 |
| Expensese paid to adminstrative service provicers from plan in this plan year | 2024-10-10 | 32830 |
| 2011 : MCLAUGHLIN BODY COMPANY PRESCRIPTION DRUG PLAN FOR RETIRED EMPLOYEES 2011 401k financial data |
|---|
| Total plan liabilities at end of year | 2011-12-31 | $0 |
| Total plan liabilities at beginning of year | 2011-12-31 | $0 |
| Total income from all sources | 2011-12-31 | $3,992 |
| Expenses. Total of all expenses incurred | 2011-12-31 | $289,455 |
| Benefits paid (including direct rollovers) | 2011-12-31 | $257,701 |
| Total plan assets at end of year | 2011-12-31 | $5,862,243 |
| Total plan assets at beginning of year | 2011-12-31 | $6,147,706 |
| Value of fidelity bond covering the plan | 2011-12-31 | $3,000,000 |
| Other income received | 2011-12-31 | $-280,384 |
| Net income (gross income less expenses) | 2011-12-31 | $-285,463 |
| Net plan assets at end of year (total assets less liabilities) | 2011-12-31 | $5,862,243 |
| Net plan assets at beginning of year (total assets less liabilities) | 2011-12-31 | $6,147,706 |
| Total contributions received or receivable from employer(s) | 2011-12-31 | $284,376 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2011-12-31 | $31,754 |
| 2010 : MCLAUGHLIN BODY COMPANY PRESCRIPTION DRUG PLAN FOR RETIRED EMPLOYEES 2010 401k financial data |
|---|
| Total plan liabilities at end of year | 2010-12-31 | $0 |
| Total plan liabilities at beginning of year | 2010-12-31 | $0 |
| Total income from all sources | 2010-12-31 | $2,901,586 |
| Expenses. Total of all expenses incurred | 2010-12-31 | $271,283 |
| Benefits paid (including direct rollovers) | 2010-12-31 | $252,604 |
| Total plan assets at end of year | 2010-12-31 | $6,147,706 |
| Total plan assets at beginning of year | 2010-12-31 | $3,517,403 |
| Value of fidelity bond covering the plan | 2010-12-31 | $3,000,000 |
| Other income received | 2010-12-31 | $630,332 |
| Net income (gross income less expenses) | 2010-12-31 | $2,630,303 |
| Net plan assets at end of year (total assets less liabilities) | 2010-12-31 | $6,147,706 |
| Net plan assets at beginning of year (total assets less liabilities) | 2010-12-31 | $3,517,403 |
| Total contributions received or receivable from employer(s) | 2010-12-31 | $2,271,254 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2010-12-31 | $18,679 |
Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.
See full terms and conditions
